Sales and Marketing

Showing 15 posts of 11524 posts found.

Pradaxa

FDA committee backs Pradaxa

September 23, 2010 Sales and Marketing Boehringer, Pradaxa, atrial fibrilation

An FDA committee has voted unanimously in favour of approving Pradaxa for stroke prevention in patients with atrial fibrillation. The …

Gilenya approved as new frontline MS treatment

September 22, 2010 Research and Development, Sales and Marketing Cladribine, FDA, Novartis, gilenya

Novartis’ new multiple sclerosis treatment Gilenya has been approved by the FDA, and is set to significantly alter the way …

Tesco to sell cut-price Viagra

September 21, 2010 Sales and Marketing Boots, Pfizer, Tesco, supermarket, viagra

Tesco has declared a price war in erectile dysfunction, announcing it will sell Viagra through its in-store pharmacies for less …

Medical, marketing & sales: making cross-functional working work

September 21, 2010 Research and Development, Sales and Marketing marketing, sales force effectiveness, sales representatives

A successful market access strategy requires the close collaboration of all functions within a pharmaceutical company. Most notably, the triumvirate …

FDA launches safety review of Actos

September 20, 2010 Sales and Marketing Actos, Takeda, diabetes

A new safety review of Takeda’s diabetes drug Actos has been launched by the FDA after a long-term study suggested …

Novartis hails longer-lasting COPD drug

September 20, 2010 Research and Development, Sales and Marketing COPD, Novartis, Onbrez Breezhaler

A phase III treatment for COPD has demonstrated superior results over GSK’s established Serevent (salmeterol). Data from Novartis’ INSIST study …

Realising outsourcing’s potential

September 20, 2010 Sales and Marketing Kinapse, White paper

IntroductionAs the budgets of pharma companies face continued downward pressure, the objective of outsourcing is not only to find effective …
Novo Dose diabetes iPhone app

Digital Pharma: Novo launches insulin dosing app

September 17, 2010 Medical Communications, Sales and Marketing Digital Pharma blog, Novo Nordisk, app, diabetes, iphone

Novo Nordisk has launched an iPhone app for US healthcare professionals that enables to them look up dosing guidelines for …

J&J to acquire Crucell for $2.3 billion

September 17, 2010 Sales and Marketing Crucell, Johnson & Johnson

Johnson & Johnson is set to buy out Crucell for around $2.3 billion (1.75 bn euros) expanding its presence in …

MSD’s Dan Heapy joins MSI

September 16, 2010 Sales and Marketing MSI, appointment, sales and marketing

The MSI Consultancy has appointed Dan Heapy as a consultant. He joins MSI from MSD, where over five years he …

AstraZeneca’s Brilinta delayed

September 16, 2010 Sales and Marketing Brillinta, Effient, Plavix, clopidogrel

AstraZeneca’s blood thinning drug Brilinta faces an extra three month delay to its review by the FDA. The US regulator …

GSK’s leukaemia drug rejected by NICE

September 16, 2010 Sales and Marketing Arzerra, GSK, NHS, NICE

GSK’s leukaemia treatment Arzerra has been rejected by NICE, which says the drug does not represent good value for the …

Gilenya approved in Russia, awaits FDA decision

September 16, 2010 Sales and Marketing Cladribine, Gilena, MS

Novartis has won approval for its MS drug Gilenya in Russia but still awaits the FDA’s decision on its fate …

Representing medium-sized pharma

September 16, 2010 Sales and Marketing European Medicines Group, UCB

UCB’s Matthew Speers is the new chairman of the European Medicines Group, which represents European-owned pharma companies in the UK. …
The Gateway to Local Adoption Series

Latest content